Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metastatic Ewing sarcoma treatment with alternating VDC/IE followed by metronomic chemotherapy
RBR-8wd7tnPhase 3Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Oct 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide and 1 more in Ewing sarcoma and primitive neuroectodermal tumor (PNET), sponsored by Hospital de Clínicas de Porto Alegre. Started Oct 2011; status: recruiting.
02
Drugs
vincristinedoxorubicincyclophosphamideifosfamideetoposide
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on RBR-8wd7tn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8wd7tn.